Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3
- PMID: 15100172
- DOI: 10.1124/dmd.32.5.505
Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3
Abstract
Carboxylesterases metabolize ester, thioester, carbamate, and amide compounds to more soluble acid, alcohol, and amine products. They belong to a multigene family with about 50% sequence identity between classes. CES1A1 and CES2 are the most studied human isoenzymes from class 1 and 2, respectively. In this study, we report the cloning and expression of a new human isoenzyme, CES3, that belongs to class 3. The purified recombinant CES3 protein has carboxylesterase activity. Carboxylesterases metabolize the carbamate prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin (CPT-11; irinotecan) to its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38), a potent topoisomerase I inhibitor. CYP3A4 oxidizes CPT-11 to two major oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin (APC) and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin (NPC). In this study, we investigate whether these oxidative metabolites, NPC and APC, can be metabolized to SN-38 by purified human carboxylesterases, CES1A1, CES2, and CES3. We find that CPT-11, APC, and NPC can all be metabolized by carboxylesterases to SN-38. CES2 has the highest catalytic activity of 0.012 min(-1) microM(-1) among the three carboxylesterases studied for hydrolysis of CPT-11. NPC was an equally good substrate of CES2 in comparison to CPT-11, with a catalytic efficiency of 0.005 min(-1) microM(-1). APC was a very poor substrate for all three isoenzymes, exhibiting a catalytic activity of 0.015 x 10(-3) min(-1) microM(-1) for CES2. Catalytic efficiency of CES3 for CPT-11 hydrolysis was 20- to 2000-fold less than that of CES1A1 and CES2. The relative activity of the three isoenzymes was CES2 > CES1A1 >> CES3, for all three substrates.
Similar articles
-
Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.Clin Cancer Res. 2003 Oct 15;9(13):4983-91. Clin Cancer Res. 2003. PMID: 14581373
-
Expression and characterization of a human carboxylesterase 2 splice variant.J Pharmacol Exp Ther. 2007 Oct;323(1):94-101. doi: 10.1124/jpet.107.127027. Epub 2007 Jul 17. J Pharmacol Exp Ther. 2007. PMID: 17636009
-
Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase.Biol Pharm Bull. 1994 May;17(5):662-4. doi: 10.1248/bpb.17.662. Biol Pharm Bull. 1994. PMID: 7920428
-
Human carboxylesterases: an update on CES1, CES2 and CES3.Protein Pept Lett. 2009;16(10):1207-14. doi: 10.2174/092986609789071324. Protein Pept Lett. 2009. PMID: 19508181 Review.
-
The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.Drug Metabol Drug Interact. 2014;29(3):143-51. doi: 10.1515/dmdi-2014-0009. Drug Metabol Drug Interact. 2014. PMID: 24988246 Review.
Cited by
-
Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock: a parallelized tool based on AutoDock 4.0.J Comput Aided Mol Des. 2010 Sep;24(9):771-87. doi: 10.1007/s10822-010-9373-1. Epub 2010 Jul 11. J Comput Aided Mol Des. 2010. PMID: 20623318
-
Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.Drug Saf. 2006;29(3):209-30. doi: 10.2165/00002018-200629030-00005. Drug Saf. 2006. PMID: 16524321 Review.
-
Discovery of dihydrooxazolo[2,3-a]isoquinoliniums as highly specific inhibitors of hCE2.RSC Adv. 2019 Nov 4;9(61):35904-35912. doi: 10.1039/c9ra07457k. eCollection 2019 Oct 31. RSC Adv. 2019. PMID: 35528066 Free PMC article.
-
Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2.Arch Biochem Biophys. 2006 Jan 1;445(1):115-23. doi: 10.1016/j.abb.2005.11.005. Arch Biochem Biophys. 2006. PMID: 16359636 Free PMC article.
-
SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.Oncotarget. 2018 May 18;9(38):25355-25382. doi: 10.18632/oncotarget.25256. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861877 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous